Janney Montgomery Scott
PTCT icon

Janney Montgomery Scott’s PTC Therapeutics PTCT Stock Holding History

Janney Montgomery Scott’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$367K Sell
5,380
-303
-5% -$21.5K ﹤0.01% 2253
2025
Q4 		$432K Hold
5,683
– – ﹤0.01% 2302
2025
Q3 		$349K Sell
5,683
-245
-4% -$12.8K ﹤0.01% 2396
2025
Q2 		$290K Hold
5,928
– – ﹤0.01% 2347
2025
Q1 		$302K Sell
5,928
-37
-0.6% -$1.85K ﹤0.01% 2301
2024
Q4 		$269K Buy
5,965
+455
+8% +$19.5K ﹤0.01% 2378
2024
Q3 		$204K Buy
+5,510
New +$184K ﹤0.01% 2503
2018
Q1 		– Sell
-26,927
Closed -$449K – 1988
2017
Q4 		$449K Sell
26,927
-900
-3% -$15.2K ﹤0.01% 1366
2017
Q3 		$557K Sell
27,827
-5,458
-16% -$107K 0.01% 1206
2017
Q2 		$610K Buy
33,285
+16,685
+101% +$225K 0.01% 1094
2017
Q1 		$163K Buy
+16,600
New +$201K ﹤0.01% 1649

Other funds holding PTCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Janney Montgomery Scott's PTCT Position: Q1 2026 in Review

Janney Montgomery Scott reduced its PTC Therapeutics (PTCT) stake by 5.3% in Q1 2026, selling an estimated $21.5K and leaving 5,380 shares worth $367K. The position accounts for ﹤0.01% of the portfolio, ranked #2253.

Janney Montgomery Scott first reported a position in PTCT in Q1 2017 and has held it in 11 quarters since. The position peaked at $610K in Q2 2017. 349 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • Janney Montgomery Scott held 5,380 shares of PTC Therapeutics worth $367K as of Q1 2026.
  • Janney Montgomery Scott sold 303 PTC Therapeutics shares in Q1 2026, an estimated $21.5K.
  • PTC Therapeutics made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q1 2026, its #2253 holding.
  • Janney Montgomery Scott first reported a position in PTC Therapeutics in Q1 2017 and has held it in 11 quarters since.
  • Janney Montgomery Scott's PTC Therapeutics position peaked at $610K in Q2 2017.
  • 349 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.